Li BE - Search Results

1

Concomitant gallstone disease was not associated with long-term outcomes in ursodeoxycholic acid-treated patients with primary biliary cholangitis.

Chen S, Li MQ, Li BE, Lv TT, Li SX, Shan S, Li M, Kong YY, Zhang D, Ma H, Ou XJ, You H, Duan WJ, Jia JD. Chen S, et al. Among authors: li be. J Dig Dis. 2023 Jun-Jul;24(6-7):419-426. doi: 10.1111/1751-2980.13207. Epub 2023 Aug 14. J Dig Dis. 2023. PMID: 37464723

2

Concomitant extrahepatic autoimmune diseases do not compromise the long-term outcomes of primary biliary cholangitis.

Chen S, Li MQ, Duan WJ, Li BE, Li SX, Lv TT, Ma L, Jia JD. Chen S, et al. Among authors: li be. Hepatobiliary Pancreat Dis Int. 2022 Dec;21(6):577-582. doi: 10.1016/j.hbpd.2022.05.009. Epub 2022 May 24. Hepatobiliary Pancreat Dis Int. 2022. PMID: 35668014

3

The future risk of primary biliary cholangitis (PBC) is low among patients with incidental anti-mitochondrial antibodies but without baseline PBC.

Duan W, Chen S, Li S, Lv T, Li B, Wang X, Wang Y, Zhao X, Ma H, Ou X, You H, Jia J. Duan W, et al. Hepatol Commun. 2022 Nov;6(11):3112-3119. doi: 10.1002/hep4.2067. Epub 2022 Aug 23. Hepatol Commun. 2022. PMID: 35998274 Free PMC article.

4

Add-on immunosuppressive therapy may benefit selected patients with primary biliary cholangitis and autoimmune phenomena.

Li M, Chen S, Li S, Lv T, Li B, Shan S, Li M, Zeng N, Wang Q, Kong Y, Ma H, Zhao X, Ou X, You H, Duan W, Jia J. Li M, et al. Therap Adv Gastroenterol. 2024 Jan 18;17:17562848231224840. doi: 10.1177/17562848231224840. eCollection 2024. Therap Adv Gastroenterol. 2024. PMID: 38250015 Free PMC article.

5

IFITM1 aggravates ConA-Induced autoimmune hepatitis by promoting NKT cell activation through increased AMPK-Dependent mitochondrial function.

Sun J, Xu H, Li B, Deng W, Han X, Zhong X, Zhu J, Jiang Y, Wang Z, Zhang D, Sun G. Sun J, et al. Int Immunopharmacol. 2025 Jan 10;144:113692. doi: 10.1016/j.intimp.2024.113692. Epub 2024 Nov 26. Int Immunopharmacol. 2025. PMID: 39602958

6

[Clinical features and long-term prognosis of primary biliary cholangitis in patients with past hepatitis B virus infection].

Li SX, Duan WJ, Li BE, Chen S, Lyu TT, Wang XM, Wang Y, Zhao XY, Ou XJ, Ma H, You H, Jia JD. Li SX, et al. Among authors: li be. Zhonghua Gan Zang Bing Za Zhi. 2023 Jul 20;31(7):705-709. doi: 10.3760/cma.j.cn501113-20220420-00215. Zhonghua Gan Zang Bing Za Zhi. 2023. PMID: 37580252 Chinese.

7

In vivo CRISPR/Cas9 screening identifies Pbrm1 as a regulator of myeloid leukemia development in mice.

Li BE, Li GY, Cai W, Zhu Q, Seruggia D, Fujiwara Y, Vakoc CR, Orkin SH. Li BE, et al. Blood Adv. 2023 Sep 26;7(18):5281-5293. doi: 10.1182/bloodadvances.2022009455. Blood Adv. 2023. PMID: 37428871 Free PMC article.

8

Zr-MOF-Induced Smart Accumulation Enables Surface-Enhanced Raman Spectroscopic Detection of Dioxin at ppt Level in Food Samples.

Cheng J, Li BE, He J, Wang P. Cheng J, et al. Among authors: li be. ACS Sens. 2023 May 26;8(5):2115-2123. doi: 10.1021/acssensors.3c00639. Epub 2023 May 15. ACS Sens. 2023. PMID: 37183968

9

Distal sacrectomy for recurrent rectal cancer.

Kernychnyi VV, Li BE. Kernychnyi VV, et al. Among authors: li be. Exp Oncol. 2021 Dec;43(4):370-372. doi: 10.32471/exp-oncology.2312-8852.vol-43-no-4.16794. Exp Oncol. 2021. PMID: 34967550

10

Mapping the evolving landscape of super-enhancers during cell differentiation.

Kai Y, Li BE, Zhu M, Li GY, Chen F, Han Y, Cha HJ, Orkin SH, Cai W, Huang J, Yuan GC. Kai Y, et al. Among authors: li be. Genome Biol. 2021 Sep 15;22(1):269. doi: 10.1186/s13059-021-02485-x. Genome Biol. 2021. PMID: 34526084 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters